IRIS
CASO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.231
NA - Nord America 4.885
EU - Europa 3.926
SA - Sud America 790
AF - Africa 141
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.674
SG - Singapore 3.355
RU - Federazione Russa 1.953
CN - Cina 1.375
VN - Vietnam 1.193
IT - Italia 673
BR - Brasile 630
HK - Hong Kong 625
FR - Francia 328
DE - Germania 209
JP - Giappone 169
IE - Irlanda 153
NL - Olanda 151
IN - India 116
CA - Canada 113
FI - Finlandia 111
GB - Regno Unito 91
KR - Corea 77
BD - Bangladesh 60
MX - Messico 57
AR - Argentina 50
SE - Svezia 49
IQ - Iraq 42
ES - Italia 35
UA - Ucraina 33
ZA - Sudafrica 33
PH - Filippine 31
PL - Polonia 29
EC - Ecuador 27
CI - Costa d'Avorio 25
CO - Colombia 23
ID - Indonesia 21
TH - Thailandia 21
TR - Turchia 20
VE - Venezuela 20
TW - Taiwan 19
AT - Austria 18
MA - Marocco 18
CH - Svizzera 16
PY - Paraguay 16
PK - Pakistan 15
SA - Arabia Saudita 14
CL - Cile 13
UZ - Uzbekistan 13
AU - Australia 11
TN - Tunisia 11
EG - Egitto 9
JO - Giordania 9
LB - Libano 9
LT - Lituania 9
BE - Belgio 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
DZ - Algeria 6
JM - Giamaica 6
KE - Kenya 6
AZ - Azerbaigian 5
BG - Bulgaria 5
ET - Etiopia 5
NP - Nepal 5
PE - Perù 5
TT - Trinidad e Tobago 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
CR - Costa Rica 4
GA - Gabon 4
GR - Grecia 4
HR - Croazia 4
HU - Ungheria 4
IL - Israele 4
LU - Lussemburgo 4
PA - Panama 4
SN - Senegal 4
UY - Uruguay 4
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BZ - Belize 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EU - Europa 2
GF - Guiana Francese 2
GN - Guinea 2
GP - Guadalupe 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LV - Lettonia 2
MR - Mauritania 2
MW - Malawi 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
Totale 16.956
Salva come PNG Salva come JPEG
Città #
Singapore 1.607
San Jose 806
Hong Kong 601
Moscow 532
Ashburn 459
Ho Chi Minh City 379
Hefei 356
Santa Clara 295
Beijing 279
Chandler 269
Hanoi 267
The Dalles 216
Naples 186
Lauterbourg 181
Millbury 179
Tokyo 156
Los Angeles 128
Des Moines 119
Amsterdam 115
Princeton 101
Boston 100
Nanjing 89
Redondo Beach 85
Buffalo 80
Napoli 71
Lawrence 63
Seoul 63
New York 55
Munich 53
Ottawa 53
Da Nang 49
Dallas 49
Wilmington 43
Frankfurt am Main 42
São Paulo 42
Milan 41
Haiphong 33
Orem 33
Nanchang 32
Rome 32
Mexico City 29
Turku 29
Seattle 28
Cava de' Tirreni 27
Chicago 26
Dublin 26
Helsinki 25
Hải Dương 22
Nuremberg 22
Brooklyn 21
Council Bluffs 21
Montreal 21
Chennai 20
Falkenstein 20
Hangzhou 20
Warsaw 20
Johannesburg 19
Baghdad 18
Belo Horizonte 17
Biên Hòa 17
Atlanta 16
New Delhi 16
Tianjin 16
Denver 15
Shanghai 15
Shenyang 15
Washington 15
Jacksonville 14
London 14
Phoenix 14
Toronto 14
Hebei 13
Phủ Lý 13
Poplar 13
Redwood City 13
Woodbridge 13
Brasília 12
Dong Ket 12
Jiaxing 12
Mumbai 12
Thái Nguyên 12
Zurich 12
Ankara 11
Bến Tre 11
Can Tho 11
Düsseldorf 11
Fairfield 11
Guangzhou 11
Porto Alegre 11
Ribeirão Preto 11
San Francisco 11
Boardman 10
Curitiba 10
Fuzhou 10
Guayaquil 10
Hyderabad 10
Manchester 10
Rio de Janeiro 10
Tashkent 10
Amman 9
Totale 9.276
Salva come PNG Salva come JPEG
Nome #
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 195
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 160
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 160
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 147
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 144
Fragility Fractures in Patients with Psoriatic Arthritis 143
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 138
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 138
IL-17-induced inflammation modulates the mPGES-1/PPAR-gamma pathway in monocytes/macrophages 136
Psoriatic arthritis and psoriasis: differential diagnosis 134
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 130
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment 129
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 128
Small molecule therapy for managing moderate to severe psoriatic arthritis 124
Dactylitis in enteropathic spondyloarthritis 122
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 122
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 120
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 120
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 119
Magnetic resonance imaging of nail unit in psoriatic arthritis 119
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 118
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 118
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 117
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 117
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 117
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 116
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 116
Exploring the dual role of Mangifera indica L. in regulating immune response and pain persistence in inflammatory bowel disease 115
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms 115
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 115
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 115
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease 114
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 114
Serum amyloid-A in Beh?et's disease. 114
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 114
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 113
IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation 113
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 113
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 112
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? 111
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 111
Simple clinical indicators for early psoriatic arthritis detection 109
Prevention of rheumatoid arthritis using a familial predictive medicine approach 108
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 108
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 108
Treatment options: NSAIDs and DMARDs 108
Biological treatments in Behçet's disease: beyond anti-TNF therapy 108
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 108
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 108
JAK Inhibitors in Psoriatic Disease 107
Refractory pemphigus foliaceus and Beh?et?s disease successfully treated with tocilizumab 107
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 107
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 107
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 103
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 102
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. 102
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 102
The definition and measurement of axial psoriatic arthritis 101
The enthesopathy of celiac patients: Effects of gluten-free diet 101
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 100
New developments in magnetic resonance imaging of the nail unit. 100
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond 99
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 99
Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers 99
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 99
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 99
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules". 98
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs 97
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 97
The enthesopathy of celiac patients: effects of gluten-free diet 96
Anakinra treatment in drug-resistant Behcet’s disease: a case series 95
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 95
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 94
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 94
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 93
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. 93
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 93
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints 93
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 92
The use of TNF-? blockers in psoriatic arthritis patients with latent tuberculosis infection. 90
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study 90
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis 89
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study 89
Blau syndrome and latent tubercular infection: an unresolved partnership 89
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 87
Diagnosis and classification of relapsing polychondritis 87
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 86
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 86
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 85
Emerging drugs for psoriatic arthritis 85
Ex vivo signaling protein mapping in T lymphocytes in the psoriatic arthritis joints 85
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 85
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 83
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 83
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients 82
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 82
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 81
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain 80
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 77
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 76
Totale 10.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.787
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 13 22 17
2021/2022771 8 6 1 0 2 33 3 34 140 32 125 387
2022/2023819 165 24 26 42 96 80 6 90 104 109 65 12
2023/2024740 32 106 120 48 33 86 16 52 13 10 142 82
2024/20255.024 404 368 25 77 88 306 503 311 439 506 1.542 455
2025/20268.895 1.093 856 957 848 1.392 393 955 790 1.172 439 0 0
Totale 17.311